Tatva Chintan Pharma Chem Ltd. IPO
IPO Timeline
Category-wise Subscription
| Category | Sub (x) | Offered | Bid For | Amt (Cr)* |
|---|---|---|---|---|
| QIB | — | 2,308,401 (50%) | — | ₹25,000 Cr |
| NII (HNI) | — | 692,521 (15%) | — | ₹7,500 Cr |
| Retail | — | 1,615,882 (35%) | — | ₹17,500 Cr |
| Σ Total | — | 4,616,804 (100%) | — | ₹500,000 Cr |
Only available investor categories are shown. Amount is auto-calculated when shares offered and issue price are available.
Issue Details
Minimum Investment (Lot-wise)
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 13 | ₹14,079 |
| Retail (Max) | 13 | 169 | ₹183,027 |
| S-HNI (Min) | 14 | 182 | ₹197,106 |
| B-HNI (Min) | 67 | 871 | ₹943,293 |
Financial Statements Amount in Crore
| Metric | 31-Mar-21 | 31-Mar-20 | 31-Mar-19 |
|---|---|---|---|
| Revenue | 306 | 265 | 207 |
| Profit After Tax | 52 | 38 | 21 |
| Total Assets | 315 | 249 | 188 |
Valuation & Key Ratios
Grey Market Premium (GMP)
GMP is an unofficial grey market indicator and does not guarantee actual listing price. Invest at your own risk.
Objects of the Issue
- 1 Funding capital expenditure requirements for expansion of our Dahej Manufacturing Facility – 147.10
- 2 Funding capital expenditure requirements for upgradation at our R&D facility in Vadodara; and – 23.97
- 3 General corporate purposes – 36.21
Company Overview
Incorporated in 1996, Tatva Chintan Pharma Chem Limited is a chemical manufacturing company that manufactures structure directing agents (SDAs), phase transfer catalyst (PTCs), pharmaceutical and agrochemical intermediates, and other specialty chemicals. It is among the largest manufacturer of SDAs for zeolites in India.
The company serves customers across industries i.e. automotive, petroleum, agrochemicals, dyes and pigments, paints and coatings, pharmaceutical, personal care, and others. Its products are not only sold in India but also export to 25+ countries all over the world such as the USA, Germany, South Africa, China, and the UK. In FY 2020, total export contributed to 76% of total revenue from operations.
Merck, Bayer AG, Ipox Chemicals, Laurus labs, Navin Fluorine International Limited, Atul Limited, Otsuka Chemicals, SRF Limited, Hawks Chemical Company, Firmenich Aromatics Prod Pvt Ltd, and Divi's laboratories are a few of customers of the company. Currently, it has two manufacturing facilities at Ankleshwar and Dahej in Gujarat.
Competitive strengths
- Leading manufacturer of structure directing agents and phase transfer catalyst.
- Diversified product portfolio.
- Global market presence with customer base across industries.
- Strategically located manufacturing facility in Gujarat with close proximity to Hazira Port.
- Experienced promoters and managers team.
- Strong financial performance track record.